BioTech Mag Search: Pharmaceutical
With Phase 2 Data in Hand, Ovid Eyes Multiple Pivotal Trials for Epilepsy Drug
Ovid Therapeutics and Takeda Pharmaceutical joined forces three years ago to develop a small molecule into a potential epilepsy drug. That research is starting to pay off as...
45 minutes ago - Xconomy - 2 articles
Pfizer Pumps $200M Into CStone for Rights to PD-L1 Cancer Drug in China
CStone Pharmaceuticals has touted its experimental drug sugemalimab as potentially the best in its class of cancer immunotherapies. Pfizer is placing a bet on that promise by...
45 minutes ago - Xconomy
Research Associate II - Inovio Pharmaceuticals - San Diego, CA
Partners and collaborators include Advaccine, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness...From Inovio...
4 hours ago - San Diego Biotechnology - 3 articles
Alnylam Reports Positive Topline Results from ILLUMINATE-B Phase 3 Study of Lumasiran for the Treatment of Primary Hyperoxaluria Type 1 in Children Under the Age of Six
CAMBRIDGE, Mass.--Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, announced today positive topline results from the ILLUMINATE-B pediatric Phase 3 study...
5 hours ago - San Diego Biotechnology - 2 articles
ProciseDx Completes Distribution Agreements with D.I.D. in Italy and BHR in the United Kingdom
SAN DIEGO, Sept. 29, 2020 /PRNewswire/ - ProciseDx Inc. has established distribution agreements with two new distributors in Europe: BHR Pharmaceuticals Ltd in the United...
1 day ago - San Diego Biotechnology
Galecto Picks Up $64M as Plans for Fibrosis Clinical Trials Move Forward
Had things turned out differently, scientists at Galecto might be watching their idiopathic pulmonary fibrosis drug candidate develop in the hands of a big pharmaceutical...
4 days ago - Xconomy
TRACON Pharmaceuticals, Inc.: Associate Director of Pharmacovigilance
TRACON Pharmaceuticals, Inc.: Reports to Chief Medical Officer. Responsible for ensuring TRACON's compliance with FDA... San Diego, CA ...
5 days ago - San Diego Biotechnology
Ionis Pharmaceuticals, Inc.: Research Associate / Senior Research Associate - Core Antisense Research
Ionis Pharmaceuticals, Inc.: For more information about Ionis and to apply for this position, please visit our website, Reference Requisition IONIS02351 San Diego County...
6 days ago - San Diego Biotechnology - 3 articles
Ligand Announces its Captisol Business is Positioned for Major Growth and Forecasts 2021 Captisol Material Sales of $200 Million
SAN DIEGO--Ligand Pharmaceuticals Incorporated announces that recent new contracting with partners and investments in manufacturing capacity have contributed to its Captisol...
7 days ago - San Diego Biotechnology
Bachem: QC Manager BSD
Bachem: Your Responsibilities The Manager of Quality Control fulfills a critical role in the active pharmaceutical ingredient manufacturing opera Vista, CA, US ...
11 days ago - San Diego Biotechnology - 3 articles
Free Registration
The headlines of BioTech Mag
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
With Phase 2 Data in Hand, Ovid Eyes Multiple Pivotal Trials for Epilepsy Drug
Ovid Therapeutics and Takeda Pharmaceutical joined forces three years ago to develop a small molecule into a potential epilepsy drug. That research is starting to pay off as...
Pfizer Pumps $200M Into CStone for Rights to PD-L1 Cancer Drug in China
CStone Pharmaceuticals has touted its experimental drug sugemalimab as potentially the best in its class of cancer immunotherapies. Pfizer is placing a bet on that promise by...
New Research Provides Clues on Optimizing Cell Defenses When Viruses Attack
UC San Diego scientists are providing new clues on how cells defend themselves from attack from viruses. The new study advance's science's understanding of interferons...
Kawasaki Disease is not a Homogenous Disease nor are its Triggers
Researchers at UC San Diego report that while Kawasaki disease occurs in clusters, the traits, and thus the triggers of the inflammatory disease vary among clusters. ...
Orphazyme Stock Sale Reaps $83M as Neimann-Pick Drug Review Begins
Orphazyme has fresh cash from the sale of shares in the US and Europe, which will support its lead rare disease drug through regulatory review and, if approved, a launch. But...
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
Praxis Precision Medicines kept mostly quiet about its research on central nervous system disorder drugs until May, when it emerged from stealth and revealed $100 million in...
Scientists Research New Ways to Tackle Brain Cancer
Glioblastoma is an aggressive brain tumor that is difficult to treat. Its cells are skilled migrators. Their knack for infiltration makes it nearly impossible for any treatment...
Shhh! These Tests Will Enable a Quieter Search for Dark Matter
Brianna Mount, assistant professor of physics at Black Hills State University, at work in the Black Hills State University Underground Campus at Sanford Lab, where components...
Spinal Cord Stimulation Reduces Pain and Motor Symptoms in Parkinson's...
A team of researchers in the United States and Japan reports that spinal cord stimulation measurably decreased pain and reduced motor symptoms of Parkinson's disease, both as a...
Genetic Testing Cost Effective for Newly Diagnosed GIST
UC San Diego School of Medicine researchers reported that genetic testing is cost-effective and beneficial for newly diagnosed patients with metastatic gastrointestinal stromal...